Skip to content

Company Architecture

Biotech Company Formation

Forming a biotech company means more than filing incorporation papers. It sets the structure, ownership, governance and early team that investors and partners will examine, and it should match the license, the research plan and the funding path the company will follow.

A board meets around a table by tall windows.

The Foundations

Entity type and jurisdiction; founder equity and vesting; the intellectual property assigned or licensed into the company; a board and advisors suited to the stage; and agreements with early contributors. Each choice is easier to make well at the start than to correct before a financing.

The Early Team

Scientific founders bring the technology. The company also needs people who have taken products through development and financing. Advisory networks and fractional roles can fill gaps until the company can hire, as long as responsibilities are clear.

Built for What Comes Next

We help founders structure the company for institutional investment and long-term growth: governance that investors recognize, ownership that keeps founders in control of their vision, and a plan that ties formation to the research and funding milestones ahead.

Common Questions

  • When should a biotech company be formed?

    Usually once there is a technology to license or assign, a founding team, and a plan for the first research and funding. Forming too early can create costs and obligations before they are needed.

  • Do founders keep control?

    Our engagement model is equity-aligned and keeps founder control and vision at the center, with structures that also meet what institutional investors expect.

Related Services

Two scientists compare results on a clipboard by a window.

Get Started

Ready to Transform Your Science into a Company?

We partner with founders and research teams committed to bringing breakthrough science to market.